Join us in Philadelphia from Sept. 25-27th for our "Together We Will" Weekend: - Register today!

The Desmoid Tumor Research Foundation

December 2016

Pazopanib: a novel treatment option for aggressive fibromatosis.

Author Information

Anil Ozluk,Atike Pınar Erdogan,Burcak Karaca,Gulcan Bulut,Nevra Elmas,Ruchan Uslu

Department of Internal Medicine, Ege University Medical School, Ege University Medical School Hospital, Ege University, Izmir, Turkey.,Department of Medical Oncology, Ege University Medical School, Tulay Aktas Oncology Hospital, Ege University, Izmir, Turkey.,Department of Radiology, Ege University Medical School, Ege University Medical School Hospital, Ege University, Izmir, Turkey.

Publication

Summary

We present the case of an AF successfully treated with an oral tyrosine kinase inhibitor, pazopanib, with mild side effects. As far as we know, this is the first case of AF with complete response to pazopanib.

View Abstract